After Moderna’s Big News, Here Are Three Biotechs to Watch
I’m following these lesser-known names amid biopharma’s move on Wednesday.
Top 6 Stocks On My Shopping List as Market Calls for Strategy Change
It’s time to change strategy as earnings season closes and seasonal weakness creeps in.
This Psychedelic Biotech Play Could See a Leg Up After Encouraging LSD Trials
The speculative action is cooling but individual names keep working.
Once These Biotech Stocks Settle Down, I’m All Over Them
As second-quarter earnings powers the market higher, I’m waiting for a chance to add to these two stocks.
Investors Turn Bullish on This Biotech Stock Heading Into Catalyst
Breadth holds up while chips fall, and this biotech chart is setting up ahead of earnings season.
Investors Are Nervous. I’m Getting Interested.
Dislocations driven by market conditions rather than fundamentals are creating my shopping list.
Stocks & Markets Podcast: Regenerative Medicine’s Next Leap with Conexeu Sciences CEO
Leveraging wound care to tackle the much larger aesthetics market.
These Two Biotechs Offer Stability in a Crazy Market
A slow and steady approach with these stable biopharma stocks offers refuge from a market that feels ready to pop.
Will the SK Hynix IPO Repeat the SpaceX Pattern?
As SKHY’s debut grabs the spotlight, the real test for the market starts next week with these three things.
I Don’t Know About You, But I’m Feeling These 22 Biotech Stocks
The market is in a transitional phase as we await earnings.